Help Center

Melt is a chocolate research product formulated with 6 mg of liraglutide per piece.

It was developed by Journi Health as part of our work exploring alternative physical formats for established pharmaceutical ingredients.

Liraglutide is a GLP-1 receptor agonist and a well-characterized pharmaceutical active ingredient.

Melt incorporates liraglutide into a chocolate-based research formulation.

Each Melt chocolate is formulated to contain 6 mg of liraglutide.

Most pharmaceutical products are built around familiar formats such as tablets, capsules and injections.

At Journi, we're interested in another question:

What other formats are possible?

Chocolate provides a low-water, lipid-rich solid matrix and can be processed under carefully controlled conditions, making it an interesting platform for formulation research.

No.

Route of administration and formulation can significantly affect how an active ingredient behaves.

The amount of liraglutide contained in a Melt chocolate should not be interpreted as equivalent to the same amount delivered through an approved injectable product.

Liraglutide is incorporated into a controlled chocolate formulation under defined processing conditions.

Our process considers factors including temperature, moisture, ingredient distribution, storage and stability.

You can learn more on our Science page.

We're developing an analytical testing program specifically for liraglutide within the finished chocolate matrix.

As validated third-party testing becomes available, we intend to publish the supporting documentation through our Testing & Certifications library.

We believe testing claims should be supported by actual documentation.

Our website distinguishes between testing that has been completed and testing that remains in progress. As third-party reports become available, they will be published for customers to review directly.

Purity generally describes how much of a tested API sample corresponds to the intended compound versus detectable impurities.

However, API purity is not the same as finished-product potency, content uniformity, stability or bioavailability.

These are different questions requiring different analytical methods.

We only want to publish claims supported by the analytical evidence available for the relevant product and batch.

Our goal is to make the underlying testing available rather than relying on a purity percentage as a marketing slogan.

Melt is currently offered for research use only.

It is not being sold as an FDA-approved drug product.

No.

Melt chocolate is not an FDA-approved drug product.

No.

Melt is offered for research purposes and is not represented as an approved treatment for any disease or medical condition.

Journi explores alternative physical formats for pharmaceutical ingredients.

Research products allow us to investigate formulation approaches, develop analytical methods and generate evidence around new formats.

Melt orders are fulfilled and shipped from the United States.

Each package contains individually wrapped Melt chocolate research units. The exact quantity and product specifications are shown on the product page before purchase.

Follow the storage conditions printed on the product packaging. Avoid excessive heat, direct sunlight and other conditions that could compromise the physical integrity of the chocolate.

Available analytical reports and product documentation can be found in our Testing & Certifications library.

As additional testing is completed, new reports will be added there.

Journi was founded by biotechnology entrepreneurs and operators with experience taking scientific products from early-stage R&D through process development, manufacturing and commercialization.

Learn more on our About Us page.